Considering the low cost, proven safety, and pharmacological efficacy of flavones, we examined their anticancer activity against CYR61-overexpressing human gastric adenocarcinoma AGS (AGS-cyr61) cells to identify flavones that can target CYR61. This evidence concerns the gene CCN1 and gastric adenocarcinoma.